Company Announcements2021-12-06T20:29:28+00:00

Company Announcements

Biophagy

Company Announcements

March 2019

Biophagy Awarded Leverage Grant

Biophagy has been awarded a new Leverage Grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Dr. Jeri Timlin and Dr. Bryan Carson). Biophagy will lead a consortium of three NM bioscience companies, including Avisa Pharma (Santa Fe, NM) and Omphalos Biosciences (Albuquerque, NM). The team will work towards identifying a lead autophagy stimulant for its program in tuberculosis and optimizing a new antibiotic in a synergistic approach to treating this infectious disease

February 2019

November 2017

Biophagy has been awarded a new Leverage Grant from New Mexico Small Business Assistance

Biophagy has been awarded a new Leverage Grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Dr. Jeri Timlin and Dr. Bryan Carson). Biophagy will lead a consortium of four NM bioscience companies, including Avisa Pharm a (Santa Fe, NM), Hyperimage Solutions (Rio Rancho, NM), and Omphalos Biosciences (Albuquerque, NM). The team will investigate proprietary autophagy stimulants and a new class of proprietary antibiotics for intracellular binding activities and in tuberculosis.

May 2017

March 2017

November 2016

Biophagy has been awarded a Leverage Grant from New Mexico Small Business Assistance

Biophagy has been awarded a Leverage Grant from New Mexico Small Business Assistance to work with Sandia National Laboratories (Jeri Timlin, PhD, and Bryan Carson, PhD). Biophagy will lead a consortium of three NM bioscience companies including Avisa Pharma (Santa Fe, NM), PureInfo Discovery (Albuquerque, NM) to investigate patented combinations of autophagy stimulants in the treatment of tuberculosis.

Categories

Go to Top